Vanguard Specialized Funds. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Shionogi & Co Ltd | 1.01% | $61.64B | 21,427,449 |
| Otsuka Holdings Co Ltd | 0.99% | $59.83B | 5,423,000 |
| Daiichi Sankyo Co Ltd | 0.96% | $58.31B | 22,675,166 |
| Chugai Pharmaceutical Co Ltd | 0.94% | $57.06B | 8,264,744 |
| Eisai Co Ltd | 0.58% | $35.11B | 7,339,417 |
| M3 Inc | 0.28% | $16.85B | 9,451,653 |
| Eli Lilly & CoLLY | 8.61% | $3.29B | 2,861,509 |
| Genmab A/S | 0.96% | $2.39B | 1,278,865 |
| Merck & Co IncMRK | 5.44% | $2.08B | 15,950,834 |
| Johnson & JohnsonJNJ | 4.83% | $1.84B | 7,191,566 |
| UnitedHealth Group IncUNH | 4.05% | $1.55B | 3,730,515 |
| AstraZeneca PLC | 4.59% | $1.30B | 10,300,505 |
| Novo Nordisk A/S | 0.41% | $1.02B | 3,322,422 |
| Edwards Lifesciences CorpEW | 2.56% | $977.58M | 11,357,910 |
| Intuitive Surgical IncISRG | 2.52% | $962.98M | 2,725,449 |
| CVS Health CorpCVS | 2.52% | $961.81M | 9,210,092 |
| Cencora IncCOR | 2.47% | $944.55M | 3,033,825 |
| Vertex Pharmaceuticals IncVRTX | 2.36% | $901.79M | 1,890,142 |
| AbbVie IncABBV | 2.30% | $879.84M | 3,506,192 |
| GSK PLC | 3.00% | $849.83M | 44,047,406 |
| Danaher CorpDHR | 2.18% | $833.57M | 4,275,150 |
| Regeneron Pharmaceuticals IncREGN | 2.14% | $817.71M | 1,072,221 |
| Elevance Health IncELV | 1.83% | $698.45M | 1,858,361 |
| HCA Healthcare IncHCA | 1.68% | $641.73M | 1,594,006 |
| Novartis AG | 1.91% | $589.00M | 4,658,547 |
| Boston Scientific CorpBSX | 1.53% | $582.92M | 12,474,112 |
| Agilent Technologies IncA | 1.49% | $570.06M | 4,119,810 |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.19% | $568.18M | 9,939,973 |
| Biogen IncBIIB | 1.46% | $557.20M | 2,745,486 |
| Argenx SE | 1.68% | $556.84M | 749,701 |
| UCB SA | 1.67% | $552.49M | 2,482,070 |
| Zai Lab Ltd | 0.17% | $520.62M | 36,431,700 |
| GenFleet Therapeutics Shanghai Inc | 0.17% | $512.30M | 18,491,938 |
| Duality Biotherapeutics Inc | 0.17% | $505.33M | 2,771,377 |
| Dexcom IncDXCM | 1.18% | $449.30M | 5,384,037 |
| Alnylam Pharmaceuticals IncALNY | 1.15% | $439.11M | 2,136,580 |
| Cardinal Health IncCAH | 1.15% | $438.06M | 1,904,367 |
| Galderma Group AG | 1.37% | $424.06M | 2,410,425 |
| Abbott LaboratoriesABT | 1.03% | $393.15M | 3,719,444 |
| Centene CorpCNC | 1.00% | $382.59M | 6,149,030 |
| Amgen IncAMGN | 0.99% | $379.25M | 984,663 |
| REVOLUTION Medicines IncRVMD | 0.98% | $372.95M | 1,988,729 |
| United Therapeutics CorpUTHR | 0.98% | $372.43M | 719,385 |
| Roche Holding AG | 1.18% | $363.91M | 1,029,839 |
| Medtronic PLCMDT | 0.95% | $361.04M | 4,228,128 |
| Stryker CorpSYK | 0.93% | $354.06M | 1,087,087 |
| Ionis Pharmaceuticals IncIONS | 0.84% | $321.63M | 6,212,640 |
| Incyte CorpINCY | 0.75% | $285.20M | 2,386,201 |
| Ascendis Pharma A/S | 0.70% | $268.27M | 1,099,854 |
| Thermo Fisher Scientific IncTMO | 0.69% | $263.59M | 458,983 |